Based on promising results from a preliminary study, Roche Pharmaceutical, which manufactures the drug valganciclovir under the brand name Valcyte, has granted $1.3 million to Dr. Jose Montoya to conduct a randomized, placebo-controlled, double-blind study set to begin this quarter at Stanford University Medical Center. The study will assess the effectiveness of the drug in treating a specific subset of CFS patients.
Very interesting. I am glad SOMEONE is working on this problem!!! I wonder “if” it will become available to us any time soon?